100% VS 80% Of Pegasys In Koreans With Chronic Hepatitis C (CHC)
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
1. Randomized controlled multicenter study
2. The response of reducing dose of peginterferon alfa-2a in Koreans with chronic hepatitis
C genotype 1
3. IL28B polymorphism in Koreans with CHC
Phase:
Phase 4
Details
Lead Sponsor:
The Catholic University of Korea
Collaborators:
Chungnam National University Hallym University Medical Center Inha University Hospital Inje University Keimyung University Konyang University Hospital Kyungpook National University Kyungpook National University Hospital National Health Insurance Service Ilsan Hospital NHIC Ilsan hospital Soonchunhyang University Hospital Ulsan University Hospital Yonsei University